Etanercept, Tocilizumab and Interleukin-1 Inhibitors in JIA Etanercept, Tocilizumab and Interleukin-1 Inhibitors in JIA
What do we currently know about the efficacy and safety of these biologic agents in the treatment of systemic onset juvenile idiopathic arthritis?Arthritis Research & Therapy
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news